Wire Stories
Incyte Announces Japanese Approval of Pemazyre� (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs)
WILMINGTON, Del. & TOKYO–(BUSINESS WIRE)–$INCY–Incyte (Nasdaq:INCY) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre� (pemigatinib),...